Abstract Objective To investigate the occurrence and possible mechanisms of apoptosis in cochlear epithelium and spiral ganglion neurons after mefloquine treatment. Methods We used quantitative RT-PCR apoptosis-fo• cused gene arrays（96-well, 84 apoptosis related genes）to assess changes of gene expression in the cochlear basilar membrane（hair cells-supporting cells）and spiral ganglion neurons of rat cochlear organotypic cultures treated with 100 μM mefloquine for 3 h. Results Significant up-or down-regulation in gene expression was detected in 23 genes in the cochlear basilar membrane, and in 32 genes in the spiral ganglion neurons compared with time-matched controls. The responding genes could be classified as pro-or anti-apoptotic, and were mainly implicated in the Bcl-2, Caspase, Card, IAP, TNF ligand／TNF receptor, Death domain／Death effector domain, DNA damage／p53, and NF-kappa B families. Synthetic analysis suggested that these families could be revised to two major pathways mainly involved in the death receptor-mediated signaling pathway and apoptotic mitochondrial pathway. In addition, it was found that numerous anti-apoptotic genes such as Bcl2a1, Birc1b, Birc3, Birc4, Bnip1, Cflar, Il10, Lhx4, Mcl1, Nfkb1, Prlr, Prok2, and TNF were greatly up-regulated in the cochlear tissue, which might imply the co-exis• tence of protective response in the cells at the early stage of mefloquine-induced damage.
Intrduction
Mefloquine is a potent antimalarial drug, widely used for prophylactic and chemotherapeutic treatment of ma• laria. As a synthetic analogue of quinine, the molecular formula, the range of clinical application, and the side-effect of mefloquine are similar to quinine. Howev• er, the neurotoxic and psychiatric side-effects of meflo• quine are more severe than quinine which include de• pression, anxiety, paranoia, aggression, nightmares, in• somnia, seizures, peripheral motor-sensory neuropathy, and many problems in the central nervous system. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] Over the past years, there has been a growing concern among government agencies about the adverse ototoxic potential of mefloquine. 7, 9, [11] [12] [13] Based on these prelimi• nary studies as well as limited clinical reports in the lit• erature concerning the ototoxic and vestibulotoxic po• tentials, the specific aim of this study is to evaluate mechanisms of mefloquine caused apoptosis in the co• chlea.
Methods

Animals
Fischer-344（F344）rats at the age of postnatal day 3 were used. Experiments were performed according to the rules and regulations of the Institutional Animal Care and Use Committee of the State University of New York at Buffalo and the National Institutes of Health Guide for the Care and Use of Laboratory Animals.
Cochlear membranous labyrinth dissection
Using techniques reported in our previous studies, postnatal day 3 F344 rats were decapitated and the co• chlear basilar membrane and spiral ganglion neurons in Rosenthal's canal were microdissected out in Hanks Balanced Salt Solution（HBSS, Invitrogen） . 14, 15 Briefly, the stria vascularis and spiral ligament were removed, and the whole cochlear basilar membrane along with the spiral ganglion neurons were dissected out under a dissection microscope in HBSS. To separate the cochle• ar basilar membrane containing the organ of Corti and the Rosenthal's canal containing spiral ganglion neu• rons, the whole Rosenthal' s canal was further separated along the inner edge of the basilar membrane.
Mefloquine treatment
Cochlear basilar membrane and Rosenthal's canal were incubated at 37℃ and 5% CO2 in a serum-free medium, with or without 100 μM of mefloquine, in 35 mm polystyrene dishes （Falcon, Becton Dickinson, Franklin Lakes, NJ）for 3 h. The serum-free medium consisted of bovine serum albumin [ Fifteen cochlear basilar membrane specimens contain• ing the organ of Corti, or fifteen Rosenthal' s canal spec• imens containing spiral ganglion neurons were treated in one dish. Mefloquine treated and non-treated speci• mens were pooled from 15 cochleae to generate one sample. Each sample was run separately for the qRT-PCR analysis. Five samples were tested, totaling 150 cochleae from 75 rats.
Quantitative RT-PCR apoptosis-focused gene arrays
In this study, we assayed the epithelium of basilar membrane containing the cochlear hair cells and sup• porting cells with or without mefloquine treatment using qRT-PCR array designed in 96-wells for the detection of 84 key apoptosis related genes. Sample preparation and the RT-PCR array determination were similar as described in our previous publications. [16] [17] [18] In brief, af• ter 3 hours of culture with or without mefloquine, co• chlear tissues were disrupted and homogenized in Buf• fer RLT. Total RNA was isolated and extracted using an RNA extraction kit（RNeasy Mini Kit, Qiagen）accord• ing to manufacturer' s protocols. The solution contain• ing extracted RNA was treated with RNase-Free DNase （Qiagen, Catalog# 79254）to remove DNA contamina• tion. After the initial extraction, the RNA solution was cleaned up using RT2 qPCR-Grade RNA Isolation Kit （SuperArray, catalog # PA-001） . The quantity of total RNA was evaluated with a spectrophotometer （Beck• man Coulter DU 640） . The amount of total RNA extract• ed from 15 cochleae was 507.6 ± 51.2 μg in epithelium of cochlear basilar membrane, and 291.2 ± 88.9 μg in spiral ganglion neurons respectively. After the RNA ex• traction and quality assessment, cDNA synthesis was performed using the kit of cDNA Synthasis Master Mix according to the manufacturer's protocols, and then cRNA amplification was performed using the kit of Am• plification Master Mix in accordance with the manufac• turer' s protocols. The RT2 Profiler PCR Array（SABio• sciences, Frederick, MD, USA) was used to measure the expression levels of apoptosis-related genes. Samples were prepared with the Master Mix and Template Cock• tail and loaded into the 96-well qRT2-PCR array. RT2-qPCR arrays were run on BioRad MyiQ thermal cycler using SYBR Green detection. Cycle thresholds were determined for each gene using the instrument' s software. Cycle threshold values were transferred into a Data Analysis Template Excel file （SuperArray） and ΔΔCt values determined for each gene in the meflo• quine-treated and control array. Fold change in expres• sion of each gene in Mefloquine was compared to Con• trol array. Table 1 The functional grouping and fold changes of responding genes in cochlear epithelium by mefloquine injury were as de• scribed in table 1. The name of genes with bold italics written are anti-apoptotic genes, while the gene name with standard type are pro-apoptotic genes.
Results
Changes in expression of apoptosis related genes in
Tnfsf10, Tradd） , Card （Birc3, Birc4, Casp1, Casp9, Cradd, Pycard） , and Cytokine receptor families（Prlr） . They are either pro-apoptotic（Bid3, Casp1, Casp7, Casp9, Cradd, Gadd45a, Pycard, Tnfsf6, Tnfsf10, Tnfsf12, Tradd）or anti-apoptotic genes （Bcl2a1, Birc3, Birc4, Bnip1, Faim, Il10, Mcl1, Nfkb1, Prlr, Prok2, Sphk2, Tnf） （Table 1） （Figure 1） . Changes in expressive of apoptosis related genes in spiral ganglion neurons．
In the tissue of spiral ganglion neurons, 32 genes showed changes in gene expression after mefloquine treatment, with 25 showing increased expression and 7 showing decreased expression. There was no expression change in the rest 52 genes. The 25 genes showing in• creased expression were Apaf1, Bcl10, Bcl2a1, Bcl2l11, Birc1b, Birc3, Casp14-predicted, Cflar, Gadd45a, Il10, Lhx4-predicated, Lta, Nfkb1, Prok2, Pycard, Ripk2, Tnf, Tnfrsf10b-predicted, Tnfrsf11b, Tnfrsf1a, Tnfrsf6, Tnfsf5, Tnfsf6, Trp63, and Trp73-predicted, and the 7 genes with decreased ex• pression were Birc5, Card6-predicted, Casp9, Cradd, Tnfsf10, Tnfsf12, Tradd. Nineteen of these genes are pro-apoptotic（Apaf1, Bcl10, Bcl2l11, Card6-predicted, Casp14-predicted, Casp9, Cradd, Gadd45a, Lta, Py• card, Tnfrsf10b-predicted, Tnfrsf11b, Tnfrsf1a, Tnfsf10, Tnfsf12, Tnfsf6, Tradd, Trp63, Trp73-predicted） and the remaining 13 genes（Bcl2a1, Birc1b, Birc3, Birc5, Cflar, Il10, Lhx4-predicated, Nfkb1, Prok2, Ripk2, Tnf, Tnfrsf6, Tnfsf5）are anti-apoptotic genes. The multiple apoptotic signals are involved in the following path• ways: the Bcl-2 family （Bcl2a1, Bcl2l11） , Caspase fam• ily（Casp14-predicted, Casp9） , IAP family （Birc1b, Birc3, Birc5） , TNF ligand / receptor family （Lta, Prok2, Tnf, Tnfsf5, Tnfsf6, Tnfsf10, Tnfsf12, Tn• frsf10b-predicted, Tnfrsf11b, Tnfrsf1a, Tnfrsf6, Tradd） , Death domain／Death effector domain family（Cflar,
Discussion
RT-PCR（reverse transcription-polymerase chain reac• tion）arrays are the most reliable tools for analyzing the expression of a focused panel of genes for mRNA detec• tion and quantification. Quantitative RT-PCR apopto• sis-focused gene array is designed for analysis of ex• pression of a panel of genes associated with numerous apoptotic biological pathways. In current apoptosis fo• cused qRT-PCR primer set, the qPCR primer assay has been tested and validated for gene-by-gene expression analysis and microarray data validation. Except the housekeeping genes, the apoptosis RT-Profiler PCR ar• ray profiles the expression of 84 key genes involved in programmed cell death which covers the possessory apoptotic pathways in the current study. Of the 84 test• ed apoptosis-related key genes included in the RT2 Profiler PCR Array, 55 are pro-apoptotic genes and 29 are anti-apoptotic genes. Whether apoptotic or an• ti-apoptotic, changes in expression of these genes are generally indicative of cellular responses to stimuli of specific apoptotic signals. Therefore, the early change genes may indicate a response to the earliest apoptotic signals, and their apoptotic pathways may be involved in the primary apoptotic mechanisms. In contrast, the unresponsive genes can be taken into account as indeci• sive genes at the early stage, and their apoptotic path• ways are supposed to be secondary apoptotic mecha• nisms in mefloquine-induced cell apoptosis in the co• Apoptosis is an occurring process to direct pro• grammed cell self-destruction. Apoptosis generally can occur through two major broad pathways: extrinsic and intrinsic pathways. The extrinsic pathway begins out• side of the cell when the cell determines to die as lethal factors appear in extracellular environment, whereas the intrinsic pathway begins when an injury occurs with• in the cell. In our previous studies, we demonstrated that mefloquine-induced apoptotic signaling in the co• chlear hair cells and spiral ganglion neurons were asso• ciated with activation of numerous caspases, particular• ly the typical involvement of the mitochondrial pathway with caspase-9 activation and cell death receptor- Table 2 The functional grouping and fold changes of responding genes in cochlear spiral ganglion neurons by mefloquine injury were as described in table 2. The name of genes with bold italics written are anti-apoptotic genes, while the gene name with stan• dard type are pro-apoptotic genes mediated signaling pathway with caspase-8 activation. 12, 13, [19] [20] [21] This indicates that the intracellular organs, such as mitochondria and cell death receptors, were injured internally by mefloquine. Generally speak• ing, mefloquine-induced intracellular apoptotic signal• ing following caspase activation should be classified as both extrinsic, involving responses from cell death re• ceptors on the cell membrane, and intrinsic, involving responses from mitochondrial apoptotic pathway.
The findings in the current study show that numerous genes and multiple apoptotic pathways are involved in mefloquine-induced apoptosis in both cochlear epitheli• um and spiral ganglion neurons. The early responding apoptotic genes in response to mefloquine injury mostly involve the Bcl-2 family, Caspase family, Card family, TNF ligand and TNF receptor family, IAP family, Death domain and Death effector domain family, DNA damage and p53 family, and NF-kappa B family. According to their functional configurations, one gene directly or indi• rectly belongs to or is related to several apoptotic fami• lies. Therefore, altered genes may arouse multiple apop• totic pathways. To better understand potential relations among these functional gene groupings, we examined in• teractions among the responding genes. Most respond• ing genes in the TNF ligand / TNF receptor family are Figure 2 Significant changes in gene expression in cochlear spiral ganglion neurons 3 hours after 100 μM mefloquine treatment. The expression in 25 genes was increased, but the expression in another 7 genes was decreased also crucial members in the DNA damage / p53 family, Death domain / Death effector domain family, and NF-kappa B family. 22 All members in the Card family possess the caspase recruitment domain which is un• doubtedly linked to the Caspase family. In addition, all members in the IAP family serve as endogenous inhibi• tors of programmed cell death, especially binding and inhibiting activation of caspases to prevent apoptosis. Therefore, the IAP family is characterized as worthy op• ponent of caspases, and its activation indirectly reflects caspases in a state of action. Apoptosis regulator Bcl-2 family governs mitochondrial outer membrane permea• bility. Thus, changes in gene expression in the Bcl-2 family are thought to be in connection with mitochondri• al degeneration. Moreover, many genes in the Bcl-2 family are also crucial members as strong prognostic in• dicators related to p53 signaling pathway. 23 The p53 pathway and its complex are hereby believed to interact with the Bcl-2 family as well. 24, 25 The mitochondrial pathway of apoptotic functions can be also triggered in response to various intracellular stress, such as the p53 signaling pathway, DNA damage, Death receptor stimu• lations, as well as reversed stimuli from the TNF ligand / receptor family, which triggers activation of a caspase cascade that shifts the balance in the Bcl-2 family. 26, 27 All factors and approaches should be taken into consid• erations in apoptotic signaling in the mitochondrial pathway, including its upstream, downstream, and other surrounding pathways.
In our previous studies, we have shown that meflo• quine damages rat cochlear hair cells and spiral gangli• on neurons in a dose-dependent manner. In addition, the initiator caspase-8 was activated 24 h after 35 μM mefloquine treatment in response to apoptotic signaling from the cell death receptors in the cell membrane. An• other initiator caspase-9 was also activated in response to cytochrome c release from damaged mitochondria, which interacted with Apaf-1, causing self-cleavage of caspase-9. These two initiator caspases, caspase-8 and caspae-9 then activated their downstream executioner caspase-3 to cleave various targets leading to cell apop• tosis. These findings suggest that mefloquine-induced apoptotic signals in caspase pathway may initiate from two aspects: damage to the cell membrane and damage to the mitocho-ndria. 12, 19, 21 Using RT-PCR apopto• sis-focused gene array to detect changes in apopto• sis-related genes 3 hours post-100 μM mefloquine, we found that nine of the 23 responding genes in the co• chlear basilar membrane, and twelve of the 32 respond• ing genes in the spiral ganglion neurons belonged to or were related to the tumor necrosis factor supper family, consistent with our previous findings in caspase-8 acti• vation 24 hours after mefloquine treatment. 2, 19, 21 In ad• dition, numerous responding genes directly belong to or are indirectly related to the apoptotic mitochondrial pathway, such as Apaf1, Bcl2a1, BCl2l11, Bid3, Birc1b, Birc3, Birc4, Bnip1, Casp1, Casp7, Casp9, Cradd, Mcl1, TNF, etc. These responding genes are in conformity with the post-mefloquine caspase-9 activation reported in our previous publications. 12, 19, 21 Therefore, the tumor necrosis factor pathway and the mitochondrial pathway are considered to be the major apoptotic pathways in mefloquine-induced cell apoptosis in the cochlear basi• lar membrane and spiral ganglion neurons. Although changes in gene expression showed a significant over• lap between the cochlear basilar membrane and spiral ganglion neurons, indicating that the major apoptotic pathways in the two structures, differences exist which may reflect the unique response in each tissue.
Changes in a wide range of apoptotic and anti-apop• totic signals in the cochlear basilar membrane （hair cells and supporting cells）and spiral ganglion neurons are observed in the current study. Changes in apopto• sis-related gene expression suggest potential changes at mRNA level in response to mefloquine-induced ear• ly apoptotic injury. While infringement of mefloquine can alter gene expression, it may not affect the function of the proteins made by the corresponding genes at the same time. Recently, we have assayed changes in the same model treated with 100 μM mefloquine for 3 hours, using an apoptosis-related antibody microarray. The proteomic analysis revealed much less expressive changes in apoptosis-related signaling proteins than in mRNA, 28 indicating that gene changes always take pre• cedence of functional changes in protein. It may also suggest a possibility of important translational control of the balance between the anti-apoptotic and the apoptot• ic responses. In our proteomic studies, some responding apoptosis-related proteins were a response or partial re• sponse to caspases activities and changes of gene ex• · · 7 pressions. For example, one of the responding proteins, mitogen-activated protein kinase, was greatly in• creased, suggesting the kinase cascade due to apoptotic signal stimulationfrom the cellular surface to the DNA in the nucleus. 29 This result is definitely consistent with caspase-8 activity and nuclear destruction we dis• covered in our previous studies 12, 19, 21 and with changes in gene expression in the TNF ligand／receptor family, caspase family, and DNA damage／p53 super family observed in the current study. In addition, decreased Caspase-3 protein expression at 3 hours post-meflo• quine 28 may represent temporary suppression of execu• tioner caspase-3 due to increased activities of an• ti-apoptotic genes in the IAP family and Bcl-2 family at the early stage of apoptosis.
In summary, the data from this study indicate that nu• merous pro-apoptotic and anti-apoptotic genes in the cochlear epithelium and spiral ganglion neurons are rapidly activated in response to mefloquine-induced apoptosis. Although multiple apoptotic pathways may be aroused by mefloquine injury, the death recep• tor-mediated signaling pathway and the mitochondrial pathway seem to be the major accesses of apoptotic pathways in mefloquine-induced cochlear apoptosis.
